These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21376658)

  • 1. Context-dependent therapeutic potential of FOXO proteins in oral squamous cell carcinoma.
    Link W
    Oral Oncol; 2011 Apr; 47(4):229-30. PubMed ID: 21376658
    [No Abstract]   [Full Text] [Related]  

  • 2. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.
    Zhang H; Nan X; Li X; Chen Y; Zhang J; Sun L; Han W; Li T
    Biochem Biophys Res Commun; 2014 May; 447(2):304-10. PubMed ID: 24721428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
    Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.
    Blessmann M; Pohlenz P; Atac A; Kaifi JT; Eulenburg C; Kalinin V; Merkert P; Smeets R; Heiland M; Blake F; Schmelzle R; Izbicki JR
    Int J Oral Maxillofac Surg; 2009 Jul; 38(7):779-84. PubMed ID: 19394797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tp63 in oral development, neoplasia, and autoimmunity.
    Romano RA; Solomon LW; Sinha S
    J Dent Res; 2012 Feb; 91(2):125-32. PubMed ID: 21646640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
    Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
    Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
    Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk estimation for a malignant transformation of oral lesions by S100A7 and Doc-1 gene expression.
    Winter J; Pantelis A; Reich R; Jepsen S; Allam JP; Novak N; Wenghoefer M
    Cancer Invest; 2011 Aug; 29(7):478-84. PubMed ID: 21740085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of oral cavity squamous cell carcinoma.
    Kupferman ME; Myers JN
    Otolaryngol Clin North Am; 2006 Apr; 39(2):229-47. PubMed ID: 16580909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of FEZ1/LZTS1 gene with frequent loss of heterozygosity in oral squamous cell carcinomas.
    Ono K; Uzawa K; Nakatsuru M; Shiiba M; Mochida Y; Tada A; Bukawa H; Miyakawa A; Yokoe H; Tanzawa H
    Int J Oncol; 2003 Aug; 23(2):297-302. PubMed ID: 12851677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer.
    Kordi-Tamandani DM; Moazeni-Roodi AK; Rigi-Ladiz MA; Hashemi M; Birjandian E; Torkamanzehi A
    Arch Oral Biol; 2010 Oct; 55(10):809-14. PubMed ID: 20674887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling the tumor-suppressive functions of FOXO proteins.
    Dansen TB; Burgering BM
    Trends Cell Biol; 2008 Sep; 18(9):421-9. PubMed ID: 18715783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of oncogenic transcription factors for oral cancer pathogenesis and treatment.
    Yedida GR; Nagini S; Mishra R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):179-88. PubMed ID: 23619350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Stat5A in tobacco chewing-mediated oral squamous cell carcinoma.
    Kar P; Supakar PC
    Cancer Lett; 2006 Aug; 240(2):306-11. PubMed ID: 16303247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.
    Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN
    Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common 9 bp deletion in the ataxia-telangiectasia-mutated gene is not associated with oral cancer.
    Spyridonidou S; Yapijakis C; Nkenke E; Toyoshima T; Vylliotis A; Serefoglou Z; Neukam FW; Patsouris E; Vairaktaris E
    Anticancer Res; 2009 Aug; 29(8):3191-3. PubMed ID: 19661334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.
    Lee CH; Wong TS; Chan JY; Lu SC; Lin P; Cheng AJ; Chen YJ; Chang JS; Hsiao SH; Leu YW; Li CI; Hsiao JR; Chang JY
    J Pathol; 2013 Jul; 230(3):298-309. PubMed ID: 23362108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy number amplification of 3q26-27 oncogenes in microdissected oral squamous cell carcinoma and oral brushed samples from areca chewers.
    Lin SC; Liu CJ; Ko SY; Chang HC; Liu TY; Chang KW
    J Pathol; 2005 Aug; 206(4):417-22. PubMed ID: 15906274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
    Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of newly established oral squamous cell carcinoma; 33-bp deletion in exons 3-4 of the p53 tumor suppressor gene.
    Hwang YS; Kim HJ; Kim J; Park KK; Chung WY
    Oral Oncol; 2012 Nov; 48(11):e39-41. PubMed ID: 22776128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.